Baby-Killing Doctor Dies; CDC Director Deadline Looms; Lyme Vax Trial Data

Note that some links may require registration or subscription.

Kermit Gosnell, MD, a doctor convicted of killing three infants delivered live at a Philadelphia abortion clinic, died at age 85. (AP)

Physicians with disabilities were more likely than non-disabled peers to consider leaving the workforce or reduce clinical hours due to burnout, health conditions, and unsafe work environments, survey data showed. (JAMA Network Open)

The deadline to nominate a CDC director is this week; a successful nominee may need to appeal to both people with Make America Healthy Again and science-first priorities. (Roll Call)

In other agency news, dozens of current and former CDC employees detailed how scientists are being sidelined while HHS Secretary Robert F. Kennedy Jr.’s allies take charge. (New York Times)

Pfizer and Valneva’s Lyme disease vaccine candidate demonstrated more than 70% efficacy in a phase III trial, but pre-determined statistical criterion for the primary endpoint was not met, the companies said.

The U.S. reported 85 new measles cases in the past week, according to the Yale School of Public Health. Here’s where they were.

Changes to a national stool bank rules made getting a fecal microbiota transplant, used to treat Clostridioides difficile infection, more difficult. (STAT)

Women were disproportionately affected by last year’s NIH grant terminations, an analysis in PNAS suggested.

Deaths from diabetes — including “type 5” diabetes, which afflicts undernourished people — are starting to rival mortality from infectious diseases in parts of Africa. (New York Times)

The House Oversight Committee will investigate California hospice fraud, alleging that millions of taxpayer dollars have been lost in improper payments to Southern California companies. (CBS News)

Kids with metabolically healthy obesity had an increased risk of cardiometabolic diseases later up to young adulthood, a cohort study in JAMA Pediatrics found.

The FDA expanded the indication of the hyaluronic acid dermal filler Restylane Contour to include temple hollowing in people ages 21 and older, maker Galderma said.

Medical manikins that can cry, sweat, bleed, brink, breathe, and convulse have become a training staple in some healthcare programs, though each manikin costs between $30,000 and $130,000. (New York Times)

EyePoint sued rival Ocular Therapeutix, alleging the company spread misleading information about EyePoint’s investigational intravitreal insert Duravyu. (Fierce Pharma)